Neuraptive's lead product, AxoFuse, is a therapeutic for use during peripheral nerve surgery to improve outcomes for patients. AxoFuse has been shown to improve recovery of function and sensation in traumatic injury and has potential for the same across a wide array of reconstructive surgical protocols. The US market opportunity consists of ~1.4m eligible patients annually representing a >$5B global market.
Funding Rounds 1
Mentions in press and media 4